{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014446","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2024-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.338610+00:00","generated_at":"2026-06-03T23:39:46.809657+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Telomir Pharma General Counsel Christos Nicholoudis resigns from GC and board effective April 10","bullets":["Christos Nicholoudis resigned as General Counsel and board member effective April 10, 2024.","Resignation was to pursue other activities; no disagreement with the company.","No replacement for General Counsel or board vacancy announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014446","json":"https://secwatch.observer/filing/0001493152-24-014446.json","markdown":"https://secwatch.observer/filing/0001493152-24-014446.md","text":"https://secwatch.observer/filing/0001493152-24-014446.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:39:46.809657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"741cb3348b","claim":"Christos Nicholoudis resigned as Board Member at Telomir Pharmaceuticals, Inc..","evidence_excerpt":"On April 10, 2024, Telomir Pharmaceuticals, Inc. (the “Company”) received written notice of resignation from Christos Nicholoudis, Esq. resigning, with immediate effect, from his positions as the General Counsel and a member of the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Board Member"}],"fact_type":"executive_change"},{"claim_id":"f467bc6dc1","claim":"Christos Nicholoudis resigned as General Counsel at Telomir Pharmaceuticals, Inc..","evidence_excerpt":"On April 10, 2024, Telomir Pharmaceuticals, Inc. (the “Company”) received written notice of resignation from Christos Nicholoudis, Esq. resigning, with immediate effect, from his positions as the General Counsel and a member of the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"General Counsel"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}